Cita APA (7a ed.)
Barroso-Sousa, R., Barry, W. T., & Tolaney, S. M. (2018). Database Selection and Heterogeneity—More Details, More Credibility—Reply...Barroso-Sousa R, BarryWT, Garrido-Castro AC, et al. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: A systematic review and meta-analysis. JAMA Oncol. 2018;4(2):173-182. doi:10.1001/jamaoncol.2017.3064. JAMA Oncology, 4(9), 1295-1297.
Cita Chicago Style (17a ed.)
Barroso-Sousa, Romualdo, William T. Barry, y Sara M. Tolaney. "Database Selection and Heterogeneity—More Details, More Credibility—Reply...Barroso-Sousa R, BarryWT, Garrido-Castro AC, Et Al. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA Oncol. 2018;4(2):173-182. Doi:10.1001/jamaoncol.2017.3064." JAMA Oncology 4, no. 9 (2018): 1295-1297.
Cita MLA (9a ed.)
Barroso-Sousa, Romualdo, et al. "Database Selection and Heterogeneity—More Details, More Credibility—Reply...Barroso-Sousa R, BarryWT, Garrido-Castro AC, Et Al. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. JAMA Oncol. 2018;4(2):173-182. Doi:10.1001/jamaoncol.2017.3064." JAMA Oncology, vol. 4, no. 9, 2018, pp. 1295-1297.
Precaución: Estas citas no son 100% exactas.